Delivering
novel cell lines to researchers to speed discoveries for Parkinson's disease
MANASSAS, Va., Oct. 8,
2015 /PRNewswire/
ATCC, the premier global biological materials
resource and standards organization, announces today that it has been selected
by The Michael J. Fox Foundation for Parkinson's Research (MJFF) to provide
vital cell lines to academic, pharmaceutical, and biotechnology organizations
committed to speed a cure for Parkinson's disease.
Parkinson's
disease is a chronic, degenerative neurological disorder that affects one in
100 people over age 60. While the average age at onset is 60, people have been
diagnosed as young as 18. Recent research indicates that at least 1 million
people in the United States, and more than 5 million worldwide, have
Parkinson's disease.
Under
the terms of the agreement, ATCC will provide services and products to the
global scientific community that is working to address this challenging disease.
Specifically ATCC will provide cell line authentication, mycoplasma testing,
and repository management services. ATCC will also produce and validate
custom master cell banks (MCBs) from macrophage cell lines provided by MJFF,
including wild-type LRRK2, LRRK2 knockout, and human LRRK2 T1348N (GTPase-dead)
knockin.
"At
our core, ATCC is about contributing to breakthrough scientific discoveries
through the provision of high quality biological products and services.
We are honored to partner with The Michael J. Fox Foundation to accelerate
breakthroughs in Parkinson's disease research," stated Raymond
Cypess, DVM, Ph.D., CEO at ATCC. "As the premier biological resource
center that global researchers have relied on for 90 years, ATCC has been
privileged to work with outstanding organizations, such as The Michael J. Fox
Foundation, and we look forward to partnering with additional
foundations."
Terina Martinez, Ph.D., associate director of
research programs at MJFF, said, "These cell lines are important tools for
our efforts to advance understanding of Parkinson's disease and further drug
development toward new therapies for the millions living with this disease.
We're pleased to be working toward these goals with ATCC, a well-regarded
organization with the capabilities and track record to help us serve the
Parkinson's research community."
This
special cell line collection will be established by the end of the first
quarter of 2016 and will be available at www.atcc.org.
About
ATCC
ATCC collaborates with and supports the
scientific community with industry-standard products and innovative solutions.
With the world's largest and most diverse collection of human, animal, and
plant cell lines, as well as molecular genomic tools, microorganisms, and
biological products, ATCC is a trusted biological resource for the worldwide
research community. Together, the people of ATCC share in its mission to
acquire, authenticate, preserve, develop, and distribute biological materials and
information for the advancement of scientific knowledge. Founded in 1925, ATCC
is a non-profit organization with headquarters in Manassas, VA. Discover
more at www.atcc.org.
About
The Michael J. Fox Foundation for Parkinson's Research
As the world's largest nonprofit funder of
Parkinson's research, The Michael J. Fox Foundation is dedicated to
accelerating a cure for Parkinson's disease and improved therapies for those
living with the condition today. The Foundation pursues its goals through an
aggressively funded, highly targeted research program coupled with active
global engagement of scientists, Parkinson's patients, business leaders,
clinical trial participants, donors and volunteers. In addition to funding
more than $450 million in research to date, the Foundation has
fundamentally altered the trajectory of progress toward a cure. Operating at
the hub of worldwide Parkinson's research, the Foundation forges groundbreaking
collaborations with industry leaders, academic scientists and government
research funders; increases the flow of participants into Parkinson's disease
clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's
awareness through high-profile advocacy, events and outreach; and coordinates
the grassroots involvement of thousands of Team Fox members around the
world.
Company contact
Renee
Randall
ATCC
Tel: (703) 365-2773
Email: rrandall@atcc.org
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/atcc-to-develop-custom-cell-lines-for-the-michael-j-fox-foundation-for-parkinsons-research-300156901.html
http://health.einnews.com/article/290590406/vuBpaUYTqhIFYygq
No comments:
Post a Comment